Follow
JK Raty
JK Raty
Validation and Security Consultant
Verified email at caliban.fi - Homepage
Title
Cited by
Cited by
Year
Challenges in monoclonal antibody-based therapies
H Samaranayake, T Wirth, D Schenkwein, JK Räty, S Ylä-Herttuala
Annals of medicine 41 (5), 322-331, 2009
1822009
Enhanced gene delivery by avidin-displaying baculovirus
JK Räty, KJ Airenne, AT Marttila, V Marjomäki, VP Hytönen, P Lehtolainen, ...
Molecular therapy 9 (2), 282-291, 2004
1352004
Baculovirus capsid display: a novel tool for transduction imaging
SP Kukkonen, KJ Airenne, V Marjomäki, OH Laitinen, P Lehtolainen, ...
Molecular Therapy 8 (5), 853-862, 2003
1312003
Gene therapy: the first approved gene-based medicines, molecular mechanisms and clinical indications
JK Raty, JT Pikkarainen, T Wirth, S Yla-Herttuala
Current molecular pharmacology 1 (1), 13-23, 2008
1252008
160. Truncated Vesicular Stomatitis Virus G-Protein Improves Baculovirus Transduction Efficiency In Vitro and In Vivo
MU Kaikkonen, JK Raty, KJ Airenne, T Wirth, T Heikura, S Yla-Herttuala
Molecular Therapy 13, S63, 2006
1052006
Non-invasive imaging in gene therapy
JK Räty, T Liimatainen, MU Kaikkonen, O Gröhn, KJ Airenne, ...
Molecular Therapy 15 (9), 1579-1586, 2007
812007
Improving safety of gene therapy
S Yla-Herttuala, JK Raty, HP Lesch, T Wirth
Current drug safety 3 (1), 46-53, 2008
702008
Magnetic resonance imaging of viral particle biodistribution in vivo
JK Räty, T Liimatainen, T Wirth, KJ Airenne, TO Ihalainen, T Huhtala, ...
Gene therapy 13 (20), 1440-1446, 2006
702006
SPECT/CT imaging of baculovirus biodistribution in rat
JK Räty, T Liimatainen, T Huhtala, MU Kaikkonen, KJ Airenne, ...
Gene therapy 14 (12), 930-938, 2007
412007
(Strept) avidin-displaying lentiviruses as versatile tools for targeting and dual imaging of gene delivery
MU Kaikkonen, HP Lesch, J Pikkarainen, JK Räty, T Vuorio, T Huhtala, ...
Gene therapy 16 (7), 894-904, 2009
232009
Avidin fusion protein strategies in targeted drug and gene delivery
OH Laitinen, KJ Airenne, JK Raty, T Wirth, S Yla-Herttuala
Letters in Drug Design & Discovery 2 (2), 124-132, 2005
102005
Development of safe and efficient viral vectors for clinical gene therapy
JK Räty, HP Lesch, S Ylä-Herttuala
Journal of Nanoneuroscience 1 (1), 35-41, 2009
32009
Baculovirus surface modifications for enhanced gene delivery and biodistribution imaging
J Räty
University of Kuopio, 2006
32006
Gene therapy: the first approved gene-based medicines, molecular mechanisms and clinical indications. Curr Mol Pharmacol 2008; 1: 13-23; PMID: 20021420
JK Raty, JT Pikkarainen, T Wirth, S Yla-Herttuala
2
Pseudotyped baculovirus and its use
KJ Airenne, S Yla-Herttuala, MU Kaikkonen, JK Raty
12006
(Strept) avidin-Displaying Lentiviruses as Versatile Tools for Vector Purification, Targeting and Dual-Imaging of Gene Delivery
MU Kaikkonen, HP Lesch, J Pikkarainen, JK Raty, T Vuorio, T Huhtala, ...
MOLECULAR THERAPY 17, S169-S170, 2009
2009
Pseudotyped Baculovirus and its Use
KJ Airenne, S Yla-Herttuala, MU Kaikkonen, JK Raty
US Patent App. 11/666,847, 2008
2008
CMR 2005: 12.06: Ultra‐small iron oxide nanoparticle (USPIO)‐labeled baculoviruses as novel MRI agents for imaging viral vector biodistribution in vivo
J Hakumäki, J Räty, T Wirth, T Huhtala, T Ihalainen, M Vihinen‐Ranta, ...
Contrast Media & Molecular Imaging 1 (2), 85-85, 2006
2006
Magnetic resonance imaging of viral particle biodistribution in vivo
J Hakumäki, J Räty, T Liimatainen, T Wirth, T Huhtala, T Ihalainen, ...
Proc. Intl. Soc. Mag. Reson. Med 14, 2006
2006
165. Tracking of Baculovirus Biodistribution In Vivo by Magnetic Resonance Imaging
JK Raty, T Wirth, KJ Airenne, T Huhtala, T Liimatainen, A Narvanen, ...
Molecular Therapy, 66, 2005
2005
The system can't perform the operation now. Try again later.
Articles 1–20